Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/25/23 16:21 | 9/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | 1 | P.m | 90 | 1.38 | 0 | 65 | 21 | 375 | D | ||||||||||||||
5/11/23 17:08 | 5/10/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | 1 | P | 47 | 1.56 | 0 | 30 | 47 | 93 | D | |||||||||||||||
5/9/23 17:00 | 5/8/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Johnson Bruce S | MD | O | SVP,Chie | 1 | P | 21 | 1.57 | 0 | 14 | 11 | 139 | D | ||||||||||||||
2/23/23 18:23 | 2/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | 3 | P.m | 3,777 | 1.96 | 0 | 1,927 | 29 | 8,489 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |